Substituted spirodienes for the treatment of inflammation
AssigneeG.D. Searle & Co.
InventorsHorng-Chih Huang, David R. Reitz
Life of this patent
Estimating the term…
Loading patent…
AssigneeG.D. Searle & Co.
InventorsHorng-Chih Huang, David R. Reitz
Estimating the term…
A class of substituted spirodienes is described for use in treating inflammation and inflammation-related disorders. Compounds of particular interest are defined by Formula III: ##STR1## wherein R.sup.3 is methylsulfonyl or sulfamyl; and wherein R.sup.8 is selected from hydrido, fluoro, chloro, bromo, iodo, methyl, ethyl, n-propyl, isopropyl, butyl, tert-butyl, isobutyl, methoxy, ethoxy, propoxy, butoxy, hydroxyl, mercapto, methylthio, ethylthio, cyano, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, pentafluoroethyl, heptafluoropropyl, difluorochloromethyl, dichlorofluoromethyl, difluoroethyl, difluoropropyl, dichloroethyl, dichloropropyl, trifluoromethoxy, hydroxymethyl, methoxymethyl and ethoxymethyl; or a pharmaceutically-acceptable salt thereof.
A compound of Formula II ##STR31## wherein each of R.sup.1, R.sup.2, R.sup.4 and R.sup.5 is hydrido;
Compound of claim 41 wherein n is 0;
A compound of Formula III ##STR32## wherein R.sup.3 is selected from methylsulfonyl and sulfamyl;
Dependencies are inferred from the claim text.